Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-08 in Interstitial Cystitis/Bladder Pain Syndrome
NCT01393223Phase 2Completed
- Sponsor
- Lipella Pharmaceuticals
- Start
- Jul 2015
- Primary completion
- Jun 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of LP-08 in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Lipella Pharmaceuticals. Started Jul 2015; status: completed.
02
Drugs
LP-08
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT01393223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393223.